KD Logo

Raymond James downgrades Disc Medicine Inc (IRON) rating to an Outperform

Disc Medicine Inc’s recent filing unveils that its Director Bitterman Kevin acquired Company’s shares for reported $8.0 million on Jun 17 ’24. In the deal valued at $36.00 per share,222,223 shares were bought. As a result of this transaction, Bitterman Kevin now holds 420,549 shares worth roughly $18.58 million.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Then, Ashiya Mona bought 83,334 shares, generating $3,000,024 in total proceeds. Upon buying the shares at $36.00, the Director now owns 941,569 shares.

Before that, ORBIMED ADVISORS LLC bought 83,334 shares. Disc Medicine Inc shares valued at $3,000,024 were divested by the Director at a price of $36.00 per share. As a result of the transaction, ORBIMED ADVISORS LLC now holds 941,569 shares, worth roughly $41.6 million.

Raymond James downgraded its Disc Medicine Inc [IRON] rating to an Outperform from a a Strong buy in a research note published recently. A number of analysts have revised their coverage, including Morgan Stanley’s analysts, who decreased its forecast for the stock in mid December from “an Overweight” to “an Equal-weight”. Raymond James also remained covering IRON and has increased its forecast on June 09, 2023 with a “Strong buy” recommendation from previously “an Outperform” rating. H.C. Wainwright started covering the stock on June 07, 2023. It rated IRON as “a Buy”.

Price Performance Review of IRON

On Friday, Disc Medicine Inc [NASDAQ:IRON] saw its stock jump 7.10% to $44.18. Over the last five days, the stock has gained 12.82%. Disc Medicine Inc shares have fallen nearly -23.51% since the year began. Nevertheless, the stocks have fallen -17.17% over the past one year. While a 52-week high of $77.60 was reached on 03/04/24, a 52-week low of $25.60 was recorded on 04/01/24. SMA at 50 days reached $33.33, while 200 days put it at $50.09. A total of 1.3 million shares were traded, compared to the trading of 0.43 million shares in the previous session.

Levels Of Support And Resistance For IRON Stock

The 24-hour chart illustrates a support level at 42.65, which if violated will result in even more drops to 41.12. On the upside, there is a resistance level at 45.31. A further resistance level may holdings at 46.44. The Relative Strength Index (RSI) on the 14-day chart is 65.11, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 2.75, which suggests price will go up in the next trading period. Percent R suggests that price movement has been low at 30.70%. Stochastics %K at 63.14% indicates the stock is a holding.

The most recent change occurred on May 17, 2023 when Raymond James began covering the stock and recommended ‘”an Outperform”‘ rating along with a $50 price target.

Most Popular